KD Logo

Monitoring AnaptysBio Inc (ANAB) after recent insider movements

AnaptysBio Inc’s recently made public that its CEO Faga Daniel unloaded Company’s shares for reported $64268.0 on Mar 25 ’24. In the deal valued at $21.42 per share,3,000 shares were sold. As a result of this transaction, Faga Daniel now holds 749,087 shares worth roughly $18.92 million.

Then, Faga Daniel sold 145,940 shares, generating $3,325,185 in total proceeds. Upon selling the shares at $22.78, the CEO now owns 752,087 shares.

Before that, LOUMEAU ERIC J sold 5,000 shares. AnaptysBio Inc shares valued at $125,000 were divested by the CHIEF LEGAL OFFICER at a price of $25.00 per share. As a result of the transaction, LOUMEAU ERIC J now holds 3,240 shares, worth roughly $81842.40000000001.

Leerink Partners initiated its AnaptysBio Inc [ANAB] rating to an Outperform in a research note published on April 16, 2024; the price target was $47. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid April with a ‘”an Overweight”‘ rating. Wedbush also remained covering ANAB and has increased its forecast on March 12, 2024 with a “an Outperform” recommendation from previously “Neutral” rating. BTIG Research started covering the stock on February 26, 2024. It rated ANAB as “a Buy”.

Price Performance Review of ANAB

On Tuesday, AnaptysBio Inc [NASDAQ:ANAB] saw its stock jump 5.29% to $25.26. Over the last five days, the stock has lost -1.64%. AnaptysBio Inc shares have risen nearly 17.93% since the year began. Nevertheless, the stocks have risen 29.87% over the past one year. While a 52-week high of $27.50 was reached on 02/26/24, a 52-week low of $13.36 was recorded on 04/25/24. SMA at 50 days reached $22.88, while 200 days put it at $20.48. A total of 0.23 million shares were traded, compared to the trading of 0.43 million shares in the previous session.

Levels Of Support And Resistance For ANAB Stock

The 24-hour chart illustrates a support level at 24.42, which if violated will result in even more drops to 23.57. On the upside, there is a resistance level at 25.77. A further resistance level may holdings at 26.28. The Relative Strength Index (RSI) on the 14-day chart is 57.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.63%. Stochastics %K at 67.17% indicates the stock is a holding.

The most recent change occurred on February 21, 2024 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.

Most Popular

[the_ad id="945"]